赛特克生物科技 CTKB
$5.83 +$0.43 (+7.96%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $5.83 0.00%
开盘$5.35
昨收$5.40
当日区间$5.31 – $5.89
成交量1.13M
市值$762.47M
市盈率（TTM）–
股息率–
财报
财报日平均波动±10.4%近16次财报
收涨次数7 / 1644% 的概率
最佳反应+36.0%
最差反应-24.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | After Market | – | -0.48% | – |
| 2026/Q1 | 7 May 2026 | After Market | – | -6.30% | – |
| 2025/Q4 | 26 Feb 2026 | After Market | – | +1.82% | – |
| 2025/Q3 | 5 Nov 2025 | After Market | – | +13.22% | – |
| 2025/Q2 | 6 Aug 2025 | After Market | – | +5.66% | – |
| 2025/Q1 | 8 May 2025 | After Market | – | -22.82% | – |
| 2024/Q4 | 27 Feb 2025 | After Market | – | -6.65% | – |
| 2024/Q3 | 5 Nov 2024 | After Market | ±38.2% | +36.03% | 符合区间 |
| 2024/Q2 | 6 Aug 2024 | After Market | ±45.9% | -9.43% | 符合区间 |
| 2024/Q1 | 8 May 2024 | After Market | ±23.1% | -1.12% | 符合区间 |
| 2023/Q4 | 28 Feb 2024 | After Market | ±21.7% | -11.90% | 符合区间 |
| 2023/Q3 | 7 Nov 2023 | After Market | – | +12.36% | – |
| 2023/Q2 | 8 Aug 2023 | After Market | ±16.3% | +0.78% | 符合区间 |
| 2023/Q1 | 9 May 2023 | After Market | ±15.7% | -24.04% | 超出定价预期 |
| 2022/Q4 | 28 Feb 2023 | After Market | – | -7.86% | – |
| 2022/Q3 | 9 Nov 2022 | After Market | ±18.6% | +5.33% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$48.14M+5.6% YoY
营业利润-$11.40M-7.3% YoY
净利润-$12.16M-117.8% YoY
摊薄每股收益-$0.09-125.0% YoY
自由现金流-$877,000.00+43.2% YoY
经营现金流$1.37M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率53.2%
营业利润率-21.6%
净利率-39.0%
净资产收益率-23.0%
资产收益率-17.1%
投入资本回报率-21.9%
流动比率4.48
负债/资产比率28.0%
现金及投资$262.00M
总负债$23.19M
净现金（净负债）$238.81M
暂无评论——快来第一个聊聊 CTKB。
登录后参与讨论。